Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jun 11, 20:15

Is BioNTech SE (BNTX) A Good Stock To Buy Now?

BioNTech SE
Webhose 2026 Jun 11, 10:03

Promising Biotech Stocks To Watch Today - June 11th - Daily Political

BioNTech SE
Webhose 2026 Jun 10, 06:30

How New Lung Cancer Data for Pumitamig Could Reshape BioNTech's (BNTX) Post-Vaccine Investment Story

BioNTech SE
Webhose 2026 Jun 09, 17:41

BioNTech (BNTX) and Bristol Myers Share New Results From ROSETTA Lung-02 Study

BioNTech SE
Webhose 2026 Jun 09, 02:37

Havemeyer Place LP Takes Position in BioNTech SE Sponsored ADR $BNTX - Daily Political

BioNTech SE
Webhose 2026 Jun 08, 07:23

BioNTech SE Sponsored ADR $BNTX Shares Sold by Capital International Inc. CA

BioNTech SE
Webhose 2026 Jun 08, 01:21

CenterBook Partners LP Grows Holdings in BioNTech SE Sponsored ADR $BNTX - Daily Political

BioNTech SE
Webhose 2026 Jun 05, 17:40

Analysts' Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Fractyl Health, Inc. (GUTS) and BioNTech SE (BNTX)

BioNTech SE
Webhose 2026 Jun 04, 10:18

Assessing BioNTech (BNTX) Valuation After Recent Share Price Weakness And Bold $499 Fair Value Narrative

BioNTech SE
Webhose 2026 Jun 04, 02:41

Recent Analysts' Ratings Updates for BioNTech (BNTX) - Daily Political

BioNTech SE
Webhose 2026 Jun 02, 10:36

How Investors May Respond To BioNTech (BNTX) Showcasing Late-Stage Oncology Data At ASCO

BioNTech SE
Webhose 2026 Jun 01, 18:08

BNTX: Leadership Upheaval And Oncology Trial Risks Will Pressure Expectations

BioNTech SE
Webhose 2026 Jun 01, 14:49

BioNTech (NASDAQ:BNTX) Earns Buy Rating from Jefferies Financial Group

BioNTech SE
Webhose 2026 Jun 01, 10:48

BioNTech (NASDAQ:BNTX) Receives "Buy" Rating from Jefferies Financial Group - Stock Observer

BioNTech SE
Webhose 2026 Jun 01, 10:18

Monaco Asset Management SAM Takes Position in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 May 31, 23:26

BMY: Promising Phase 2 Results for Pumitamig in Lung Cancer Treatment

BioNTech SE
Webhose 2026 May 31, 08:26

How Is Pfizer's Stock Performance Compared to Other Healthcare Stocks?

BioNTech SE
Webhose 2026 May 31, 07:27

BNP Paribas Financial Markets Raises Stock Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 May 31, 06:44

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

BioNTech SE
Webhose 2026 May 30, 00:00

Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial | Valuespectrum.com

BioNTech SE
Webhose 2026 May 29, 08:04

BioNTech Board Expansion Signals Focus On Oncology Execution And Valuation Gap

BioNTech SE
Webhose 2026 May 27, 18:50

BNTX Upgraded by UBS -- Price Target Raised to $135

BioNTech SE
Webhose 2026 May 27, 03:10

BioNTech (BNTX) Valuation Check After New Late Stage Oncology Data At 2026 ASCO Meeting

BioNTech SE
Webhose 2026 May 23, 02:49

BioNTech (NASDAQ:BNTX) Upgraded at Sanford C. Bernstein - Daily Political

BioNTech SE
Webhose 2026 May 21, 21:20

Bernstein starts BioNTech at Market Perform, sees high registration risk

BioNTech SE
Webhose 2026 May 21, 10:27

Leonteq Securities AG Invests $2.61 Million in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 May 21, 05:26

Did Adding Oncology Veterans to the Supervisory Board Just Shift BioNTech's (BNTX) Investment Narrative? - Simply Wall St News

BioNTech SE
Webhose 2026 May 17, 08:23

Assessing BioNTech (BNTX) Valuation After Prolonged Share Price Weakness And Loss Making Results

BioNTech SE
Webhose 2026 May 16, 00:00

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

BioNTech SE
Webhose 2026 May 15, 21:01

Biontech SE Annual Shareholders Meeting Transcript

BioNTech SE
Webhose 2026 May 15, 16:10

BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM

BioNTech SE
Webhose 2026 May 15, 00:00

BioNTech comes to Jerusalem: Mayor Moshe Lion announces new mRNA vaccine center

BioNTech SE

BioNTech News

Emma Rose 2026 Jun 13, 00:00

Fed's New Era: Warsh Signals Caution Amid Inflation and Market Jitters

Sophia Claire 2026 Jun 13, 00:00

Storage Chip Sector Rebound: Is AI Sustaining the Cycle?

Emma Rose 2026 Jun 13, 00:00

New Fed Chair Kevin Warsh: Reshaping Communication and Steering Market Expectations

Sophia Claire 2026 Jun 13, 00:00

Goldman Sachs Revises 2027 Brent Crude Forecast to $80/bbl Amid Shifting Supply and Demand Dynamics

Emma Rose 2026 Jun 13, 00:00

US Stock Market Volatility Surges as Trading Logic Breaks Down

Julian Parker 2026 Jun 10, 16:01

SpaceX IPO Puts S&P 500 Inclusion Question in Focus

stocks
Julian Parker 2026 Jun 09, 16:02

US CPI Preview: Higher Inflation Could Reinforce Fed Rate-Hike Bets

commodity
Ghko B 2026 Jun 07, 16:01

CFD Trading Strategies: How to Cash In on the World Cup Stock Market Curse with CFD Shorts

cfd trading
Ghko B 2026 Jun 07, 16:01

A CFD Trading Guide for South Africa: Can ZA CFD Traders Profit from the FIFA World Cup Market Effect?

cfd trading
Vance X 2026 Jun 07, 16:00

What Is NFP in Trading? How to Trade the Nonfarm Payroll Report

Latest news

Show more
Sophia Claire 2026 Jun 13, 00:00

Qatar's Delicate Energy Diplomacy Amidst Regional Conflict: A Balancing Act

Emma Rose 2026 Jun 13, 00:00

Lebanon: A Geopolitical Chessboard of Iranian Influence and US Diplomacy

Liam James 2026 Jun 13, 00:00

Global Market Snapshot: Key Events and Analysis of Financial Markets

Noah Lee 2026 Jun 13, 00:00

BoJ Policy Meeting Under Scrutiny Amid Governor's Health, Rate Hike Expectations

Emma Rose 2026 Jun 13, 00:00

US-Iran Standoff: Peak Pressure Tactics Amidst Hopes for a Diplomatic Breakthrough

Noah Lee 2026 Jun 13, 00:00

US Strategy on Hormuz Strait: Will Capturing Kharg Island Backfire?

Liam James 2026 Jun 13, 00:00

NATO Security Posture and US Military Adjustments: Divergent Risk Assessments Between the US and Europe

Sophia Claire 2026 Jun 13, 00:00

Hormuz Strait Shipping Landscape Shifts Amidst Easing Tensions and Strategic Maneuvers

Info

Spread

1.1330

Spread (%)

1.2597 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

21785978880

Shares Outstanding

252884261

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-5.84

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin and cyclophosphamide; and drugs under Phase 2/3 clinical trial, such as BNT113 for human papillomavirus and head and neck squamous cell carcinoma, as well as Pumitamig for metastatic colorectal and non-small cell lung cancer. In addition, the company engages in the development of oncology drugs under Phase II clinical trial comprising BNT116 for advance non-small cell lung cancer, BNT326/YL202 for multiple solid tumors and advanced/metastatic breast cancer, Autogene cevumeran for advance colorectal cancer, and Gotistobart for platinum-resistant ovarian cancer, as well as Pumitamig for glioblastoma, hepatocellular carcinoma, malignant pleural mesothelioma, neuroendocrine neoplasms, and metastatic pancreatic ductal adenocarcinoma. Further, it develops BNT166 which is Phase II clinical trial for mpox virus; and infectious diseases drugs under Phase 1/2 clinical trial, which include BNT162 + BNT161 for SARS-CoV-2 and influenza, BNT164 for tuberculosis, BNT165 for malaria, and BNT166 for mpox. The company was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Julian Parker 2026 Jun 11, 16:04

Most Volatile Forex Pairs: What Traders Should Know

Julian Parker 2026 Jun 11, 16:02

What Happens on the Day of an IPO?

Julian Parker 2026 Jun 10, 16:04

10 Hot IPO Stocks to Watch in 2026: SpaceX, Anthropic, OpenAI and More

Trustpilot